{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:17:21Z","timestamp":1793157441570,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":363,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1136\/esmoopen-2020-000803","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T03:15:34Z","timestamp":1599534934000},"page":"e000803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1042-8521","authenticated-orcid":false,"given":"Amit A.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ebadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad A.","family":"Meybodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumithira","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2752-945X","authenticated-orcid":false,"given":"Manish Ramesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/esmoopen-2020-000803_bb0010","author":"Honda"},{"key":"10.1136\/esmoopen-2020-000803_bb0015","author":"Verdam"},{"key":"10.1136\/esmoopen-2020-000803_bb0020","author":"Tlaskalov\u00e1-Hogenov\u00e1"},{"key":"10.1136\/esmoopen-2020-000803_bb0025","author":"Kamada"},{"key":"10.1136\/esmoopen-2020-000803_bb0030","author":"Lynch"},{"key":"10.1136\/esmoopen-2020-000803_bb0035","author":"Peled"},{"key":"10.1136\/esmoopen-2020-000803_bb0040","author":"Routy"},{"key":"10.1136\/esmoopen-2020-000803_bb0045","author":"Pinato"},{"key":"10.1136\/esmoopen-2020-000803_bb0050","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1016\/j.jtho.2018.08.397","article-title":"MA10.03 plasmatic evaluation of the intestinal barrier and blood microbiota, and antibiotic use in non-small cell lung cancer patients treated with nivolumab","volume":"13","author":"Ouaknine","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1136\/esmoopen-2020-000803_bb0055","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1016\/j.jtho.2018.08.396","article-title":"MA10.02 impact of antibiotics on outcome of metastatic non small cell lung cancer patients treated with immunotherapy","volume":"13","author":"Galli","year":"2018","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1136\/esmoopen-2020-000803_bb0060","author":"Ahmed"},{"key":"10.1136\/esmoopen-2020-000803_bb0065","author":"Hakozaki"},{"key":"10.1136\/esmoopen-2020-000803_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2018.08.395","article-title":"MA10.01 antibiotic use and PD-1 inhibitors: shorter survival in lung cancer, especially when given intravenously. type of infection also matters","volume":"13","author":"Mielgo-Rubio","year":"2018","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1136\/esmoopen-2020-000803_bb0075","author":"Wilson"},{"key":"10.1136\/esmoopen-2020-000803_bb0080","author":"Sen"},{"key":"10.1136\/esmoopen-2020-000803_bb0085","author":"Tinsley"},{"key":"10.1136\/esmoopen-2020-000803_bb0090","author":"Matson"},{"key":"10.1136\/esmoopen-2020-000803_bb0095","author":"Elkrief"},{"key":"10.1136\/esmoopen-2020-000803_bb0100","author":"Gopalakrishnan"},{"key":"10.1136\/esmoopen-2020-000803_bb0105","author":"Huang"},{"key":"10.1136\/esmoopen-2020-000803_bb0110","author":"Huemer"},{"key":"10.1136\/esmoopen-2020-000803_bb0115","author":"Derosa"},{"key":"10.1136\/esmoopen-2020-000803_bb0120","author":"Zhao"},{"key":"10.1136\/esmoopen-2020-000803_bb0125","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.6_suppl.607","article-title":"Antibiotic use and outcomes with systemic therapy in metastatic renal cell carcinoma (mRCC)","volume":"36","author":"Lalani","year":"2018","journal-title":"JCO"},{"key":"10.1136\/esmoopen-2020-000803_bb0130","article-title":"Association of medication (Med) and antibiotic (abx) use with response and survival in advanced melanoma (MEL) receiving PD-1 inhibitors","volume":"37","author":"Hemadri","year":"2019","journal-title":"JCO"},{"key":"10.1136\/esmoopen-2020-000803_bb0135","author":"Schett"},{"key":"10.1136\/esmoopen-2020-000803_bb0140","author":"Viaud"},{"key":"10.1136\/esmoopen-2020-000803_bb0145","author":"Iida"},{"key":"10.1136\/esmoopen-2020-000803_bb0150","author":"D\u00f6hner"},{"key":"10.1136\/esmoopen-2020-000803_bb0155","author":"Weber"},{"key":"10.1136\/esmoopen-2020-000803_bb0160","author":"Scott"},{"key":"10.1136\/esmoopen-2020-000803_bb0165","author":"Ekmekciu"},{"key":"10.1136\/esmoopen-2020-000803_bb0170","author":"Abu-Sbeih"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292032696X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292032696X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/esmoopen-2020-000803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:23:49Z","timestamp":1761855829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292032696X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["S205970292032696X"],"URL":"https:\/\/doi.org\/10.1136\/esmoopen-2020-000803","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/esmoopen-2020-000803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"e000803"}}